September 10, 2020 |
Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:
ROUNDTABLE: Wednesday, September 23, 13:00
Exploring Digital Therapeutics
Moderated by: Olaf Schoeman, MSc, Director and German Lead
Presentation: Thursday, September 24, 14:30
EUnetHTA Joint Assessments and Implications for the Industry
Rosemary Jose, PhD, Director and Commercial Lead, Strategic Market Access
We welcome you to schedule a meeting with one of our team members Rosemary Jose, Olaf Schoeman, Marja Hensen, Walter Bouwmeester, Andrew Revel, Marie Keetley or Phil Drew to discuss your market access, HEOR and real-world evidence needs.
OPEN Health is a family of expert practices working in partnership to drive positive change in healthcare communications and market access globally. It all started with a vision to create a new, unique entity equipped to be a global leader in HEOR, market access, medical and patient brand communications and digital services. By bringing together the Pharmerit and OPEN VIE teams to create the Evidence and Access practice, we have expanded our global footprint and capabilities in HEOR and market access. This newly integrated team provides world-class knowledge, insight and outputs across the entire spectrum of market access and reimbursement, evidence generation, gathering and evaluation, and population-based health data. Our multidisciplinary teams work across four centers of excellence:
Together, we have grown to over 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China. What makes us different is our deeply integrated teams working collaboratively to bring the strategic and technical expertise needed to be a solid partner to our sponsors. Combine this with our broad scope of therapeutic expertise to produce results and solutions that are of the highest quality. We pride ourselves on having a highly skilled, diverse, and connected team working across the globe to deliver truly innovative and best-in-class solutions. This has resulted in long-term, flexible partnerships that span many years across multiple brands and therapy areas.
For more information on how we are improving the lives of patients, worldwide, please visit www.openhealthgroup.com
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Paul Morrissey, Global Business Director, OPEN Health
Written by OPEN Health's Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Louise Carrington and Gemma Allen, OPEN Health
OPEN VIE (Amanda Pulfer, Strategic Director and Sergio Diaz, Patient Centred Outcomes Consultant) were delighted to speak at the Medical Affairs Leaders Forum yesterday.
Celeste Kolanko, Managing Director, Liberum OPEN Health
Turning scientific knowledge and data into evidence
Emily Wigginton, Client Services Director, OPEN Health Patient & Brand Communications
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes.
Dr Tyler Ray, OPEN Health Medical Communications
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts